Khiron Life Sciences Looks To Acquire PharmaDrug’s German Subsidiary For $2.0 Million

Khiron Life Sciences Corp. (TSXV: KHRN) announced today the plan to acquire Pharmadrug GmbH, a German cannabis subsidiary of PharmaDrug Inc. (CSE: PHRX). The total consideration for the transaction is estimated at $2.0 million.

“This acquisition will provide us with a European manufacturing and distribution centre for cannabinoid-based medicines with EU-GMP certification,” said Khiron Europe President Franziska Katterbach.

The transaction will partially be satisfied with the issuance of 5.5 million Khiron common shares at $0.16 per share. The Canadian cannabis firm will also issue a non-interest-bearing promissory note for $1.1 million which will be payable within one year after closing either via cash or company shares.

The companies expect the acquisition to close in July 2022, subject to regulatory approvals and customary closing conditions.

The German subsidiary carries a Schedule I European Union narcotics license, an EU-GMP certification, and an EU-GDP certification–fulfilling the region’s standards in manufacturing and distributing pharmaceutical products.

The acquisition plans follow Khiron’s first foray into the European market back in November 2021 through the opening of its first Zerenia Clinics UK in London.

Khiron Life Sciences last traded at $0.17 on the TSX Venture.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A Gold District Hidden In Plain Sight!? | Michael Bennett – Altamira Gold

200 Grams of Gold And 21% Copper — That’s Not Normal | Matt Wilson – Sterling Metals

Silver at $100? This Time It Might Stay There. | David Morgan

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Khiron Life Sciences Conducts Bought Deal Financing For Gross Proceeds Of $10.0 Million

Khiron Life Sciences (TSXV: KHRN) announced that it is conducting at $10.0 bought deal private...

Monday, November 9, 2020, 08:43:24 AM

Pharmadrug Completes Super Smart Acquisition, Issues 64.4 Million Free Trading Shares

Pharmadrug Inc (CSE: BUZZ) announced this morning that it has completed its acquisition of Interrobang...

Monday, June 15, 2020, 02:44:06 PM

Khiron Life Sciences Announces First Medical Cannabis Clinic In Europe

Khiron Life Sciences Corp. (TSXV: KHRN) announced today the opening of Zerenia Clinics UK in...

Wednesday, November 3, 2021, 11:03:00 AM

Khiron Signs Exclusive Partnership with Rappi, The Amazon Of South America

Khiron Life Sciences (TSXV: KHRN) this morning announced the significant development of establishing an exclusive...

Friday, September 4, 2020, 08:17:02 AM

Khiron Life Pushes Through Extensive Lockdowns In Second Quarter With Revenues Of $1.7 Million

Khiron Life Sciences (TSXV: KHRN) reported its second quarter financials this morning, recording $1.67 million...

Monday, August 24, 2020, 10:10:03 AM